Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.
about
Auditory dysfunction in schizophrenia: integrating clinical and basic features.Mismatch negativity: translating the potentialGone to Pot - A Review of the Association between Cannabis and PsychosisFuture clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophreniaContributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosisA Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and ProgressionElectrophysiological Endophenotypes for SchizophreniaElectrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder.Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic Youth.Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.Mismatch negativity (MMN) as an index of cognitive dysfunctionThe five myths of MMN: redefining how to use MMN in basic and clinical researchUsing biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnessesMismatch negativity in recent-onset and chronic schizophrenia: a current source density analysis.Auditory prediction errors as individual biomarkers of schizophrenia.Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode PsychosisEquivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients.Auditory mismatch negativity and repetition suppression deficits in schizophrenia explained by irregular computation of prediction errorMismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders.Contributions of experimental psychiatry to research on the psychosis prodrome.Translational psychiatry--light at the end of the tunnel.Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophreniaMapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia.Impairment in predictive processes during auditory mismatch negativity in ScZ: Evidence from event-related fields.Altering the course of schizophrenia: progress and perspectives.A Meta-analytic Review of Auditory Event-Related Potential Components as Endophenotypes for Schizophrenia: Perspectives From First-Degree Relatives.Ethical and Epidemiological Dimensions of Labeling Psychosis Risk.Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.Neural mechanisms of mismatch negativity dysfunction in schizophrenia.Prediction and prevention of psychosis: current progress and future tasks.No association between symptom severity and MMN impairment in schizophrenia: A meta-analytic approach.Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia.
P2860
Q26796401-8A568040-469E-48C0-AED6-95DEC25372CAQ26830827-FC31C2F3-1100-4BFF-94BD-FDEE43D38D64Q26865311-D2DBABD2-2F9C-49D2-8A7C-C86A45D73C2BQ27014120-6CBE1473-C5D3-4640-A6CB-41E14082F483Q27303931-2EB68361-77A7-4D4C-8779-391A6AA859D0Q30354141-C6057D1B-F5E8-4973-BA88-40E8ABBC9E01Q30362188-F6CC0969-5DBD-4F50-86AB-3F8AE7081DADQ30362549-F5DE32D7-0C92-4EBA-AEE3-FC55E3CB2D2BQ30367531-CEFA112D-4C67-4ACB-994D-01EC28817B57Q30371792-ACDA4A26-5905-4CDF-ACDC-66CFF8D806D9Q30384452-AB9FB1D2-06B3-48A5-855D-91EF229240CEQ30387378-E624F5EC-5BEC-435A-8A1B-94FFD9FCA815Q30391026-2D55ED01-CAFB-430A-94F6-A56A70357187Q30394589-C6D716CC-7FDE-4862-85DF-EBF4826F1BFCQ30407708-C05B1024-23FA-4F71-AF96-5E7F51FE3FA1Q30407711-75687B61-2100-40B6-AD6B-7006293CE0AFQ30421612-21C8BC9B-B8C0-48A1-89C6-EA5429E62684Q30436122-29D035A4-5E73-4AB0-B111-31EBBCC52C4BQ33700032-0C60925D-E899-4AC6-B476-D59588A9C9C1Q33720060-F07A8B85-D0AA-46EC-AEA9-D13C61749567Q35108892-6E775FD0-8FD3-4C92-A0FA-F489C6D4144BQ35587074-29A23160-A42B-4936-9306-9C0C499B85FAQ37191789-B1F0EA30-895D-4CC6-BA5B-DB3991A01C74Q38175023-155A8648-B42D-478F-8B9A-517DED702C38Q38370696-D60B9171-594D-4C24-AD61-C80F714892CEQ38495807-02C04003-C547-45BF-9339-555C9BB932D5Q38606268-A110E739-78B1-4C41-8B54-28A1A3A8C58CQ38650161-16416A06-B6F7-49A6-9573-E8ACE2FCF8C3Q38677502-D16CD685-98D0-4226-A4D9-AAE1B0176CAAQ38678400-FE113761-6B94-4BAA-9732-207AA438AEEEQ38693536-F7232FEA-C0BA-4E03-9B61-8F254877F797Q38759421-55456B8E-092D-44F5-9A61-28639BE7D3E2Q38842717-B5D7BD70-7795-4D82-9982-6F8042BBE728Q38870720-5B696DA4-34B8-4402-A925-D15A9DB2FFDAQ38929213-81349789-CDA0-4FFC-81DC-28F420C52A99Q38975275-8EC91215-0571-4C2C-A850-9532C8E19001Q39123249-44D9C530-6B63-4371-81D6-42097359BC0EQ41040762-5C9D9D85-3787-440E-A171-EFD9845FDF24Q46116077-E18C4FAF-422C-429D-9A97-3D376FE269ADQ46495642-A649FF33-0595-4EBF-A680-FF2D1F6A3354
P2860
Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Automatic auditory processing ...... risk with mismatch negativity.
@ast
Automatic auditory processing ...... risk with mismatch negativity.
@en
type
label
Automatic auditory processing ...... risk with mismatch negativity.
@ast
Automatic auditory processing ...... risk with mismatch negativity.
@en
prefLabel
Automatic auditory processing ...... risk with mismatch negativity.
@ast
Automatic auditory processing ...... risk with mismatch negativity.
@en
P2093
P2860
P50
P921
P1476
Automatic auditory processing ...... risk with mismatch negativity
@en
P2093
Judith M Ford
Scott W Woods
Thomas H McGlashan
Veronica B Perez
P2860
P304
P356
10.1016/J.BIOPSYCH.2013.07.038
P407
P577
2013-09-16T00:00:00Z